Opioids Should Not Be Used in Migraine

被引:56
|
作者
Tepper, Stewart J. [1 ]
机构
[1] Cleveland Clin, Headache Ctr, Cleveland, OH 44195 USA
来源
HEADACHE | 2012年 / 52卷
关键词
opioid; migraine; narcotic; acute treatment; chronic migraine; nociception; PREVENTION AMPP; HEADACHE; PREVALENCE; MEDICATIONS; ANALGESICS; DEPENDENCE; DIAGNOSIS; EM;
D O I
10.1111/j.1526-4610.2012.02140.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Opioids should not be used for the treatment of migraine. This brief review explores why not. Alternative acute and preventive agents should always be explored. Opioids do not work well clinically in migraine. No randomized controlled study shows pain-free results with opioids in the treatment of migraine. Saper and colleagues' 5-year study showed minimal effectiveness, with many contract violations, interfering with the therapeutic alliance. The physiologic consequences of opioid use are adverse, occur quickly, and can be permanent. Decreased gray matter, release of calcitonin gene-related peptide, dynorphin, and pro-inflammatory peptides, and activation of excitatory glutamate receptors are all associated with opioid exposure. Opioids are pro-nociceptive, prevent reversal of migraine central sensitization, and interfere with triptan effectiveness. Opioids precipitate bad clinical outcomes, especially transformation to daily headache. They cause disease progression, comorbidity, and excessive health care consumption. Use of opioids in migraine is pennywise and pound foolish.
引用
收藏
页码:30 / 34
页数:5
相关论文
共 50 条
  • [41] Prescription Opioids in Patients With Migraine in Southern Israel: a Retrospective Database Analysis
    Asla, Mohnnad
    Peles, Ido
    Abayev, Mariya
    Gordon, Michal
    Novack, Victor
    Ribalov, Rinat
    Lengil, Tamar
    Maor, Ron
    Elizur, Mayera
    Ifergane, Gal
    NEUROLOGY, 2022, 98 (18)
  • [42] Appliances used in migraine prevention therapy
    J Steele
    British Dental Journal, 2006, 200 (5) : 269 - 269
  • [43] PROPRANOLOL USED IN PROPHYLAXIS OF MIGRAINE IN CHILDREN
    LUDVIGSSON, J
    ACTA NEUROLOGICA SCANDINAVICA, 1974, 50 (01): : 109 - 115
  • [44] Geographic variation in the use of triptans and opioids for the acute treatment of migraine attacks
    Lee, Jae Hyun
    Shewale, Anand R.
    Barthold, Douglas
    Devine, Beth
    HEADACHE, 2021, 61 (10): : 1499 - 1510
  • [45] Endogenous Opioids Mediate the sTMS Effects in the Sensory Thalamus of Migraine Models
    Andreou, A. P.
    Fredrick, J.
    Goadsby, P. J.
    CEPHALALGIA, 2013, 33 (S8) : 11 - 12
  • [46] Daily Scheduled Opioids as Monotherapy for Prevention of Migraine-Triggered Epilepsy
    Derakhshan, Iraj
    DRUG RESEARCH, 2018, 68 (01) : 60 - 60
  • [47] Quantity fluctuations of illicitly used opioids and overdose risk
    Rowe, Christopher
    Wheeler, Eliza
    Vittinghoff, Eric
    Santos, Glenn-Milo
    Behar, Emily
    Coffin, Phillip O.
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2018, 58 : 64 - 70
  • [48] Opioids could potentially be used to remove memory of pain
    Attwood, Claire
    PAIN MANAGEMENT, 2012, 2 (02) : 107 - 107
  • [49] In Vitro Hepatotoxicity of Routinely Used Opioids and Sedative Drugs
    Haller, Katharina
    Doss, Sandra
    Sauer, Martin
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2024, 46 (04) : 3022 - 3038
  • [50] Is Telcagepant Effective in Migraineurs Who Previously Used Opioids?
    Ho, Andrew P.
    Kost, James T.
    Dahlof, Carl G. H.
    Silberstein, Stephen D.
    Froman, Samar
    Leibensperger, Heather
    Lines, Christopher R.
    Ho, Tony W.
    NEUROLOGY, 2010, 74 (09) : A574 - A574